Fig. 5From: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitisKaplan-Meier analysis of overall survival in patients with stage IV melanoma. Median not reached in IFX or CS group. Median follow-up 26Â monthsBack to article page